Signing out of account, Standby...
Terrence W. Norchi
CEO of Arch Therapeutics, Inc.
Terrence W. Norchi, MD is president and CEO of Framingham, MA-based Arch Therapeutics, Inc. Arch’s flagship development stage product candidate, the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.
Follow Terrence W. Norchi on Social
More Authors You Might Like
Founder of Ogline Digital
CEO of Edgemesh
Founder and CEO of Outsource Accelerator
Dr. Julia Colangelo
Flow + Mindfulness Educator, Writer, Speaker, Consultant
CEO & Co-founder of Novakid
Founder of Humanalysts
CEO of Boomers Parks